MS is a chronic, life-long, disease which has no cure.

In patients with MS, the protective layer that coats the nerve cells in the brain and spinal cord (called myelin) is damaged by the body’s own immune system. This damage hinders the ability of the nerve cells to transmit signals. Although significant advances in treatment have been made, not all patients are responsive to all therapies and there is no method for predicting which patients will respond best to each treatment. This project will investigate if current MS treatments can make changes to DNA.


C A/Prof Jeannette Lechner-Scott, Katherine Sanders, Rebecca Seeto

Research Area 
Project type 
Year of funding